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Abstract
Background: Sequencing-based analyses of low-biomass samples are known to be prone to misinterpretation due
to the potential presence of contaminating molecules derived from laboratory reagents and environments. DNA
contamination has been previously reported, yet contamination with RNA is usually considered to be very unlikely
due to its inherent instability. Small RNAs (sRNAs) identified in tissues and bodily fluids, such as blood plasma, have
implications for physiology and pathology, and therefore the potential to act as disease biomarkers. Thus, the
possibility for RNA contaminants demands careful evaluation.
Results: Herein, we report on the presence of small RNA (sRNA) contaminants in widely used microRNA extraction
kits and propose an approach for their depletion. We sequenced sRNAs extracted from human plasma samples and
detected important levels of non-human (exogenous) sequences whose source could be traced to the microRNA
extraction columns through a careful qPCR-based analysis of several laboratory reagents. Furthermore, we also
detected the presence of artefactual sequences related to these contaminants in a range of published datasets,
thereby arguing in particular for a re-evaluation of reports suggesting the presence of exogenous RNAs of microbial
and dietary origin in blood plasma. To avoid artefacts in future experiments, we also devise several protocols for the
removal of contaminant RNAs, define minimal amounts of starting material for artefact-free analyses, and confirm
the reduction of contaminant levels for identification of bona fide sequences using ‘ultra-clean’ extraction kits.
Conclusion: This is the first report on the presence of RNA molecules as contaminants in RNA extraction kits. The
described protocols should be applied in the future to avoid confounding sRNA studies.
Keywords: RNA sequencing, Artefact removal, Exogenous RNA in human blood plasma, Contaminant RNA, Spin
columns
Background
The characterisation of different classes of small RNAs
(sRNAs) in tissues and bodily fluids holds great promise
for understanding human physiology as well as in
health-related applications. In blood plasma, microRNAs
and other sRNAs are relatively stable, and microRNAs
in particular are thought to reflect a system-wide state,
making them potential biomarkers for a multitude of
human diseases [1, 2]. Different mechanisms of sRNA
delivery as a means of long-distance intercellular com-
munication have been recognised in several eukaryotes
[3–10]. In addition, inter-individual, inter-species and
even inter-kingdom communications via sRNAs have
been proposed [11–15], and cases of microRNA-based
control by the host [16, 17] or pathogens [18, 19] have
been demonstrated.
Additionally, exogenous RNAs have been reported in
the blood plasma of humans and mice [20, 21], sparking a
heated debate around the genuineness of these observa-
tions [22–25]. While bacteria do secrete RNAs via outer
membrane vesicles [26–28], the potential for exogenous
RNA-based signalling in mammals is also the subject of
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significant current debate [29, 30]. Diet-derived exogenous
microRNAs have been proposed to exert an influence on
human physiology [31, 32], but these findings have been
refuted by others due to a lack of reproducibility in valid-
ation studies [33–37]. This discussion happens at a time
when DNA sequencing-based analyses of low-biomass
samples have been recognised as prone to being con-
founded by contaminants [38]. From initial sample hand-
ling [39], to extraction kits [40], to sequencing reagents
[41], multiple sources of DNA contamination and artefac-
tual sequencing data have been described.
Herein, we report on the contamination of widely
used silica-based columns for the isolation of micro-
and other sRNAs with RNA, which was apparent from
sRNA sequencing data and was subsequently validated
by qPCR. These artefactual sRNA sequences are also
apparent in numerous published datasets. Furthermore,
approaches for the depletion of the contaminants from
the columns as well as an evaluation of a newer ultra-
clean kit are presented, along with the determination of
a minimum safe input volume to suppress the signal of
the contaminant sequences in RNA sequencing data of
human blood plasma samples. The potential presence
of bona fide exogenous sRNA species in human plasma
is examined. Finally, recommendations for the control
and interpretation of sRNA sequencing data from low-
biomass samples are provided.
Results
Initial detection of exogenous sRNAs in human blood plasma
sRNA was extracted from 100 μL of blood plasma samples
of 10 healthy individuals and sequenced using regular
RNeasy columns (workflow in Fig. 1). The read profiles
were mined for putative exogenous (non-human) sequences
(see Methods). Among the potential exogenous sequences
were 19 sequences that occurred with more than 1000
counts per million (cpm) in all samples. To rule out se-
quencing errors or contamination during sequencing library
preparation, a qPCR assay was developed to assess the pres-
ence of non-human sequences in the sRNA preparations
from plasma. Six of the 19 highly abundant sRNA se-
quences from plasma that could not be mapped to the hu-
man genome were chosen for validation by qPCR (Table 1).
qPCR assays for putative exogenous sRNAs in human
blood plasma
Synthetic sRNAs with the putative exogenous se-
quences found in plasma were poly-adenylated and
reverse transcribed to yield cDNA, and used for opti-
misation of PCR primers and conditions (Table 1). All
primer sets yielded amplicons with single peaks in
melting temperature analysis with efficiency values
above 80%. The optimised qPCR assays were then
employed to test for the presence of the highly abun-
dant sRNAs potentially representing exogenous se-
quences (workflow in Fig. 1) in the human plasma
samples used for the initial sequencing experiment. The
qPCR assays confirmed the presence of these sRNAs in
the sRNA preparations used for sequencing (Fig. 2a),
yielding amplicons with melting temperatures expected
from the synthetic sRNAs. No amplification was ob-
served if the poly-adenylation or the reverse transcrip-
tion step were omitted. To rule out contamination of
the water used in the sRNA preparations, a water con-
trol was also examined. No amplification was observed
in all but one assay, where amplification of a product
with a different melting temperature occurred (Fig. 2a).
Thus, for the assays, water contamination could be
ruled out.
Non-human sequences derived from column contaminants
To analyse whether the validated non-human sequences
occurring in the sRNA extracts of plasma were present
in any lab-ware, a series of control experiments were
carried out (Additional file 1: Figure S1). When nucleic
acid- and RNase-free water (QIAGEN) was used as
input to the miRNeasy Serum/Plasma kit (QIAGEN)
instead of plasma (‘mock extraction’), all tested non-
human sequences could be amplified from the mock
extract (Fig. 2b), indicating that one of the components
of the extraction kit or lab-ware was contaminated with
the non-human sequences. To locate the source of con-
tamination, mock extractions were performed by omit-
ting single steps of the RNA isolation protocol except
for the elution step. Amplification from the resulting
mock extracts was tested for the most abundant
non-human sequence (sRNA 1). In all cases, the sRNA
Fig. 1 Workflow of the initial screen for and validation of exogenous sRNA sequences in human plasma samples
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1 could be amplified (data not shown). We therefore
performed a simple experiment in which nucleic
acid- and RNase-free water was passed through an
otherwise untreated spin column. From this column
eluate, all target sequences could be amplified (Fig. 2b),
in contrast to the nucleic acid- and RNase-free water
(Fig. 2a). The most abundant non-human sequences in
the plasma sequencing experiments were therefore
most likely contaminants originating from the RNeasy
columns.
Table 1 Sequences of non-human sRNAs found in plasma preparations, synthetic sRNA templates, primers and annealing
temperatures









sRNA 1 (CU)AACAGACCGAGGACUUGAA(U) 133,700 algae AACAGACCGAGGACTTGAA 57 °C
sRNA 2 ACGGACAAGAAUAGGCUUCGGCU 8000 fungi or
plants
ACGGACAAGAATAGGCTTC 54 °C
sRNA 3 GCCUUGGUUGUAGGAUCUGU 8200 plants GCCTTGGTTGTAGGATCTGT 57 °C
sRNA 4 GCCAGCAUCAGUUCGGUGUG 6800 bacteria CAGCATCAGTTCGGTGTG 57 °C
sRNA 5 GAGAGUAGGACGUUGCCAGGUU 3900 bacteria AGTAGGACGTTGCCAGGTT 57 °C
sRNA 6 UUGAAGGGUCGUUCGAGACCAGGACGUUGAUAGGCUGGGUG 3400 bacteria GAAGGGTCGTTCGAGACC 57 °C
hsa-miR486-5p UCCUGUACUGAGCUGCCCCGAG human –* 60 °C
* hsa-miR486-5p specific assay from Quanta BIOSCIENCES
a b
c d
Fig. 2 Detection of non-human sRNA species in column eluates and their removal from columns: a qPCR amplification of six non-human sRNA
species in extracts from human plasma and qPCR control (water). b Detection of the same sRNA species in mock extracts without input to extract
columns and water passed through extraction columns (‘eluate’). c Levels of the same sRNA species in mock extracts without and with DNase
treatment during the extraction. d Relative levels of sRNA remaining after pre-treatment of extraction columns with bleach or washing ten times
with water, detected after eluting columns with water. All: mean results of three experiments, measured in reaction duplicates; error bars represent
one standard deviation; data points are available in Additional file 2: Tables S7–S10. Experiments displayed in panels b and d were performed on the
same batch of columns, a and c on independent batches
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Detection of contaminant sequences in public datasets
To assess whether our observation of contaminant sRNAs
was also pertinent in other sequencing datasets of low-
input samples, the levels of confirmed contaminant sRNA
sequences in published datasets [20, 21, 34, 42–59] were
assessed. Irrespective of the RNA isolation procedure
applied, non-target sequences were detected (making up
between 5% and over 99% of the sequencing libraries for
the human samples; Additional file 2: Table S2). As shown
in Fig. 3, the six contaminant sequences which had been
confirmed by qPCR were found in all analysed low bio-
mass samples extracted with regular miRNeasy kits, but
the sequences were found at lower levels in studies with
more biomass input [34, 43, 45] and hardly ever [46] in
studies where samples were extracted using other
methods (Additional file 2: Table S2). Within each study
where the confirmed contaminant sequences were de-
tected, the relative levels of the contaminant sequences
were remarkably stable (Additional file 3: Figure S2).
Depletion of contaminants from isolation columns
In order to eliminate contamination from the columns to
allow their use in studies of environmental samples or po-
tential exogenous sRNAs from human samples, we were
interested in the nature of these contaminants. The fact
that they can be poly-adenylated by RNA-poly-A-polymer-
ase and need to be reverse-transcribed before amplification
indicates to them being RNA. Treatment of the eluate with
RNase prior to cDNA preparation also abolished amplifica-
tion (data not shown), but on-column DNase digestion did
not reduce their levels (Fig. 2c). Thus, these findings sug-
gest that the contaminants were RNAs.
Contaminating sequences could potentially be removed
from the RNeasy columns using RNase, but as RNases are
notoriously difficult to inactivate and RNases remaining
on the column would be detrimental to sRNA recovery,
an alternative means of removing RNA was deemed desir-
able. Loading and incubation of RNeasy columns with the
oxidant sodium hypochlorite and subsequent washing
with RNase-free water to remove traces of the oxidant re-
duced the amplifyability of unwanted sRNA by at least
100 times (Fig. 2d) while retaining the columns’ efficiency
to isolate sRNAs from samples applied afterwards. Elimin-
ation of contaminant sRNAs from the RNeasy columns by
washing with RNase-free water (Fig. 2d; average ± stand-
ard deviation of the contaminant reduction by 80 ± 10%)
or treatment with sodium hydroxide (70 ± 15%) was not
sufficient to completely remove the contaminants.
Ultra-clean extraction kits
Recently, RNeasy columns from an ultra-clean produc-
tion have become available from QIAGEN within the
miRNeasy Serum/Plasma Advanced Kit. We compared
the levels of the previously analysed contaminant se-
quences in the flow-through of mock extractions using
four batches of ultra-clean RNeasy columns to two
batches of the regular columns by qPCR. In all cases,
marked reductions in the contaminant levels were ob-
served in the clean columns (Fig. 4a; 4 to 4000 fold; me-
dian 60). To obtain an overview of other potential
contaminants, sRNA sequencing of the mock extracts
from these six batches of spin columns was performed.
With regards to the six previously analysed contaminant
sequences, the results were similar to those of the qPCR
assays (Additional file 4: Figure S3). Additionally, for the
ultra-clean RNeasy columns, a smaller spectrum of other
potential contaminant sequences was observed (Fig. 4b,
c) and those sequences made up a smaller proportion of
the eluate sequences (Fig. 4d).
As our initial analyses of plasma samples extracted using
regular RNeasy spin columns had revealed contaminant
levels of up to 7000 cpm, we were interested to define a safe
input amount for human plasma for both column types
that would be sufficient to suppress the contaminant signals
to below 100 cpm. For this, we performed a titration ex-
periment (Additional file 4: Figure S3b), isolating sRNA
from a series of different input volumes of the same human
plasma sample on four batches of RNeasy columns (two
batches of regular columns, two batches of ultra-clean col-
umns) with subsequent sequencing. As expected from re-
agent contaminants, the observed levels of the contaminant
sequences were generally inversely dependent on the
plasma input volume (Fig. 5a). In addition, and in accord-
ance with the earlier mock extraction results, the levels of
contaminant sequences were lower or they were completely
absent in the ultra-clean columns (see levels for 100 μL in-
put in Fig. 5b). An input volume of 100 μL of plasma was
Fig. 3 Detection of contaminant sequences in published sRNA
sequencing datasets of low biomass samples. Datasets are referenced
by NCBI bioproject accession or first author of the published
manuscript. n number of samples in the dataset, E extraction kit used
(if this information is available), Q regular miRNeasy (QIAGEN), T TRIzol
(Thermo Fisher), P mirVana PARIS RNA extraction kit (Thermo Fisher), V
mirVana RNA extraction kit with phenol, Rpm reads per million. Error
bars indicate one standard deviation
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sufficient to reduce all contaminant sequences to below
100 cpm when using the ultra-clean spin columns.
Potential plasma-derived exogenous RNAs
Finally, to assess whether any potential exogenous
sRNAs might be present in human plasma, we mined
the plasma datasets used in the well-controlled titration
experiment for sequences that did not originate from
the human genome or from known contaminants of se-
quencing reagents and were not detected in any of the
mock-extracts. On average, 5% of the sequencing reads
of sRNA isolated from plasma did not map to the hu-
man genome; 127 sequences which did not map to the
human genome assembly hg38 were detected in the ma-
jority of the plasma samples and were not represented in
the control samples (empty libraries, mock extractions,
column eluates or water). Out of these, 3 sequences had
low complexity; 81 sequences could be exactly matched
to sequences in the NCBI-nr that are not part of the
current version of the human genome assembly (hg38)
but annotated as human sequences, or had best partial
matches to the human genome or to sequences from
other vertebrates; and, of the 43 remaining sequences,
which matched best to bacterial, fungal or plant se-
quences, 22 matched best to the genomes of genera that
have previously been identified as contaminations of se-
quencing kits [41] and were removed. The remaining 21
sequences displayed very low relative abundances close
to the detection limit (always below 50 cpm, mean below
5 cpm) in the 28 datasets derived from a single plasma
sample from the one healthy individual (Additional file 5:
Figure S4). Their potential origins were heterogeneous,
including a plant, fungi and bacteria, with an enrichment
in partial or perfect hits to Lactobacillus sequences
(Additional file 2: Table S2). No signature of dietary or
common gut microbial organisms was observed.
Discussion
Several instances of contamination of laboratory re-




Fig. 4 Confirmed and potential contaminant sequences in eluates of regular and ultra-clean RNeasy spin columns: a Levels of contaminant
sequences in eluates of two batches of regular and four batches of ultra-clean spin columns, based on qPCR; ultra-clean batches 1 and 2 are
cleaned-up versions of regular batch 2 and ultra-clean batches 3 and 4 are cleaned-up versions of regular batch 3; error bars indicate one
standard deviation; data points are available in Additional file 2: Table S11. b and c Numbers of different further potential contaminant sequences
on the regular and ultra-clean spin columns from two different batches. d Total levels of further potential contaminant sequences, based on sRNA
sequencing data normalised to spike-in levels. Cpm counts per million
a b
Fig. 5 Titration experiment: Detection of contaminants in sRNA preparations of human plasma using different input volumes and extraction columns.
a Detected levels of the six contaminant sRNA sequences in sRNA sequencing data of preparations using 0 to 1115 μL human plasma and regular or
ultra-clean RNeasy spin columns. b Detailed view of the data displayed in a for 100 μL of human plasma as input to regular and ultra-clean RNeasy spin
columns. Cpm counts per million. Error bars indicate one standard deviation; data points are available in Additional file 2: Table S12
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sequencing data, have been reported in recent years
[38, 41, 60, 61]. In contrast, the contamination of re-
agents with RNA has not yet been reported. Contamin-
ation with RNA is usually considered very unlikely due
to the ubiquitous presence of RNases in the environ-
ment and RNA’s lower chemical stability given its ten-
dency towards hydrolysis, especially at higher pH.
However, our results suggest that the detected contami-
nants were not DNA, but RNA, because treatment with
RNase and not DNase decreased the contaminant load.
In addition, the contaminating molecules could not be
amplified without poly-adenylation and reverse tran-
scription. The stability of the contaminants is likely due
to the extraction columns being RNase-free and their
silica protecting bound sRNAs from degradation.
The results presented here focused on one manufac-
turer’s spin column-based extraction kit, which is com-
monly used in studies on samples with low RNA
content, in particular human blood plasma, on which this
kit was used because it was amongst those showing the
highest yields in studies comparing different kits [62–
65]. However, other RNA-stabilising or extraction re-
agents may carry RNA contamination. Based on the ana-
lysis of the published datasets, where significant
numbers of sequences that did not map to the source
organism’s genome were found to be independent of the
RNA extraction kit used, potential contaminants in
other extraction kits would have different sequences
than those confirmed by qPCR herein. As suggested by
previously observed significant batch effects of sequen-
cing data derived from samples extracted with a number
of different extraction kits [24], the contaminants may
also qualitatively and quantitatively change over time. It
is therefore highly recommended to properly control the
different sample handling procedures and RNA isolation
steps for contaminants when assessing unexpected
RNAs in low biomass samples, independent of the ex-
traction kit.
The methods presented here should also help to re-
assess the question of whether exogenous sRNA species
derived from oral intake [21] or the microbiome [20,
44, 66] really occur in human plasma or are merely ar-
tefacts [23]. The limited data source from this study
(one healthy person) points to very low levels and a
small spectrum of potential foreign sRNAs without an
obvious link to diet and which may have been intro-
duced during venipuncture, which is impossible to con-
trol for. Additional data from a large number of
subjects will be required to make any conclusive state-
ments in this context.
The reported contaminant sequences can confound
studies of organisms whose transcriptomes contain se-
quences similar to the contaminants. While they are not
abundant enough to confound biomarker studies in hu-
man plasma by dilution effects, they may lead to the over-
estimation of miRNA yields in low-biomass samples. They
can also give rise to misinterpretation in studies without a
priori knowledge of the organisms present.
Conclusions
Care has to be taken when analysing low-input samples,
in particular for surveys of environmental or otherwise
undefined sources of RNAs. A number of recommenda-
tions can be conceived based on the presented data
(Fig. 6). First, extraction columns should be obtained as
clean as possible. Second, simple clean-up procedures
can also reduce contaminants. Third, the input mass of
sRNA should be as high as possible, e.g. for human
plasma, volumes above 100 μL are preferable. Fourth,
extraction controls should always be sequenced with
the study samples. To facilitate library preparation for
the extraction controls, spike-in RNAs with defined se-
quences can be used and should be applied at concen-
trations similar to the levels of RNA found in the study
samples. As the spike-in signal can drown out the con-
taminants, it is necessary to avoid concentrations that
are too high for the spike-ins. Fifth, sequences found in
the extraction controls should be treated as artefacts
and removed from the sequencing data. Independent
techniques that are more robust to low input material,
such as qPCR or ddPCR, should be applied to both
study samples and controls in case of doubt.
Fig. 6 Summary: Recommendations for artefact-free analysis of sRNA by sequencing
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Methods
Blood plasma sampling
Written informed consent was obtained from all blood
donors. The sample collection and analysis was ap-
proved by the Comité d’Ethique de Recherche (CNER;
Reference: 201110/05) and the National Commission for
Data Protection in Luxembourg. Blood was collected by
venepuncture into EDTA-treated tubes. Plasma was pre-
pared immediately after blood collection by centrifuga-
tion (10 min at 1000 × g) and platelets were depleted by
a second centrifugation step (5 min at 10,000 × g). The
blood plasma was flash-frozen in liquid nitrogen and
stored at −80 °C until extraction.
Use of sRNA isolation columns
Unless stated otherwise, 100 μL of blood plasma was
lysed using the QIAzol (QIAGEN) lysis reagent prior to
binding to the column, as recommended by the manu-
facturer. RNeasy MinElute spin columns from the miR-
Neasy Serum/Plasma Kit (QIAGEN) were then loaded,
washed and dried, and RNA was eluted as recommended
by the manufacturer’s manual. We further tested four
batches of ultra-clean RNeasy MinElute columns, which
underwent an ultra-clean production process to remove
potential nucleic acid contamination, including environ-
mental sRNAs. These columns were treated as recom-
mended in the manual of the miRNeasy Serum/Plasma
Advanced Kit (QIAGEN). All eluates were stored at
−80 °C until analysis.
For the mock extractions, ultra-clean or regular RNeasy
columns were loaded with the aqueous phase from a QIA-
zol extraction of nucleic acid- and RNase-free water (QIA-
GEN) instead of plasma. For mock extractions with a
defined spike-in, the aqueous phase was spiked with syn-
thetic hsa-miR-486-3p RNA (Eurogentec) to yield 40,000
copies per μL of eluate. To obtain column eluates, spin
columns were not loaded, washed or dried. Instead, 14 μL
of RNase-free water (QIAGEN) was applied directly to a
new column and centrifuged for 1 min. In the plasma ti-
tration experiment, plasma input volumes of 45, 100, 225,
500, and 1115 μL and 100 μL of RNase-free water that
had been pre-processed analogously to the plasma sam-
ples were used for the QIAzol (QIAGEN) step.
To eliminate environmental sRNAs from the regular
RNeasy columns, the columns were incubated with
500 μL of a sodium hypochlorite solution (Sigma; di-
luted in nuclease free water (Invitrogen) to approx. 0.
5%) for 10 min at room temperature. Columns were
subsequently washed 10 times with 500 μL of nuclease
free water (Invitrogen), before use. Similarly, in the
attempt to remove sRNAs by application of sodium
hydroxide, 500 μL of 50 mM NaOH were incubated on
the spin columns for 5 min, followed by incubation
with 50 mM HCl for 5 min, prior to washing the
columns 10 times with 500 μL of nuclease-free water
(Invitrogen) before use.
Real-time PCR
Eluted RNA (5 μL) was polyadenylated and reverse-
transcribed to cDNA using the qScript microRNA cDNA
Synthesis Kit (Quanta BIOSCIENCES). cDNA (1 μL, ex-
cept for the initial plasma experiment, where 0.2 μL of
cDNA were used) was amplified by use of sequence-
specific forward primers (see Table 1, obtained from Euro-
gentec) or the miR486-5p-specific assay from PerfeCTa
Universal PCR Primer and PerfeCTa SYBR Green Super-
Mix (Quanta BIOSCIENCES) in a total reaction volume
of 10 μL. Primers were added at a final concentration of 0.
2 μM. Primer design and amplification settings were opti-
mised with respect to reaction efficiency and specificity.
Efficiency was calculated using a dilution series covering
seven orders of magnitude of template cDNA reverse
transcribed from synthetic sRNA. Real-time PCR was per-
formed on a LightCycler® 480 Real-Time PCR System
(Roche) including denaturation at 95 °C for 2 min and
40 cycles of 95 °C for 5 s, 54–60 °C for 15 s (for annealing
temperatures see Table 1), and 72 °C for 15 s. All reactions
were performed in duplicate. No-template controls were
performed analogously with water as input. Controls with-
out reverse transcriptase were performed with the mock
extract experiments and did not yield amplicons. Cp
values were obtained using the second derivative proced-
ure provided by the LightCycler® 480 Software, Version 1.
5. Absolute quantification of sRNAs in the eluates was
enabled by the dilution series of defined concentrations of
synthetic sRNAs with the same sequence as the target
sRNAs. Linear regression of the CT against the log10
concentration was performed to yield the intercept b and
slope m, which were used to calculate the number of
sRNAs in the test samples 10(b – CT/–m).
sRNA seq: library preparation and sequencing
sRNA libraries were made using the TruSeq small RNA
library preparation kit (Illumina) according to the man-
ufacturer’s instructions, except that the 3′ and 5′
adapters were diluted 1:3 before use. PCR-amplified
libraries were size selected using a PippinHT instru-
ment (Sage Science), collecting the range of 121 to
163 bp. Completed, size-selected libraries were run on
a High Sensitivity DNA chip on a 2100 Bioanalyzer
(Agilent) to assess library quality. Concentration was
determined by qPCR using the NEBNext Library Quant
kit. Libraries were pooled, diluted and sequenced with
75 cycle single-end reads on a NextSeq 500 (Illumina)
according the manufacturer’s instructions. The sequen-
cing reads can be accessed at NCBI’s short read archive
via PRJNA419919 (for sample identifiers and accessions
see Additional file 2: Table S1).
Heintz-Buschart et al. BMC Biology  (2018) 16:52 Page 7 of 11
Initial analysis: plasma-derived sRNA sequencing data
For the initial analysis of plasma-derived sRNA sequen-
cing data, FastQC [67] was used to determine over-
represented primer and adapter sequences, which were
subsequently removed using cutadapt [68]. This step was
repeated recursively until no over-represented primer or
adapter sequences were detected. 5’-Ns were removed
using fastx_clipper of the FASTX-toolkit. Trimmed reads
were quality-filtered using fastq_quality_filter of the
FASTX-toolkit (with -q 30 -p 90) [69]. Finally, identical
reads were collapsed, retaining the read abundance infor-
mation using fastx_collapser of the FASTX-toolkit. The
collapsed reads were mapped against the human genome
(GRCh37), including RefSeq exon junction sequences, as
well as prokaryotic, viral, fungal, plant and animal ge-
nomes from GenBank [70] and the Human Microbiome
Project [71] using Novoalign V2.08.02 (Additional file 2:
Tables S3 to S5) [72]. These organisms were selected
based on their presence in the human microbiome, hu-
man nutrition and the public availability of the genomes.
As reads were commonly mapping to genomic sequences
of multiple organisms, and random alignment can easily
occur between short sequences and reference genomes,
the following approach was taken to refine their taxo-
nomic classification. First, reads were attributed to the hu-
man genome if they mapped to it. Secondly, reads
mapping to each reference genome were compared to
mapping of a shuffled decoy read set. Based on this, the
list of reference genomes was limited to the genomes
recruiting at least one read with a minimum length of
25 nt. Loci on non-human genomes were established by
the position of the mapping reads. The number of map-
ping reads per locus was adjusted using a previously estab-
lished cross-mapping correction [73]. Finally, the
sequences of the loci, the number of mapping reads and
their potential taxonomy were extracted.
sRNA sequence analysis of controls
For the subsequent analysis of the mock extractions, col-
umn eluates, and nucleic acid- and RNase-free water, as
well as of no-template controls and human plasma sam-
ples, extracted using either regular or ultra-clean RNeasy
columns, the trimming and quality check of the reads was
performed analogously to the description above. Collapsed
reads were mapped against the most recent version of the
human genome (hg38) either to remove operator-derived
sequences or to distinguish the reads mapping to the hu-
man genome in the different datasets. Sequencing was
performed in two batches, with one batch filling an entire
flow cell, and one mixed with other samples. The latter
batch of samples was sequenced on the same flow cell as
sRNAs extracted from Salmonella typhimurium LT2. To
avoid misinterpretations due to multiplexing errors, reads
mapping to Salmonella typhimurium LT2 [74] (GenBank
accession AE006468) were additionally removed in this
batch. To limit the analysis to only frequently occurring
sequences and therefore avoid over-interpretation of erro-
neous sequences, only read sequences that were found at
least 30 times in all analysed samples together were
retained for further analysis. Public sRNA datasets of low-
input samples (Additional file 2: Table S1) were analysed
in a fashion analogous to the study’s control and plasma
samples. As the published studies consisted of different
numbers of samples, no overall threshold was imposed,
but to limit the analysis to frequently occurring sequences,
singleton reads were removed.
To compare the sequencing results to the qPCR-based
results and to detect the same sequences in public data-
sets, reads matching the sequences assayed by qPCR
were determined by clustering the trimmed, filtered and
collapsed sRNA reads with 100% sequence identity and
14 nt alignment length with the primer sequences, while
allowing the sRNA reads to be longer than the primer
sequences, using CD-HIT-EST-2D (parameters -c 1 -n 8
-G 0 -A 14 -S2 40 -g 1 -r 0) [75].
To compare the diversity and levels of putative con-
taminant sequences in the different samples, identical
reads derived from all study samples (that did not map
to the human genome) were clustered using CD-HIT-
EST [75], and a table with the number of reads se-
quenced for each sample per sequence was created using
R v.3.0.2. To obtain estimates of absolute numbers of
contaminant sequences, the cpm of non-human se-
quences were normalised to the cpm of the spike-in hsa-
miR-486-5p, whose abundance was determined both
from the sequencing as well as the qPCR experiments.
The table of counts of identical sequences per sample
was also used to extract candidate sequences from the
study plasma samples that are likely exogenous plasma
sRNAs, based on the following criteria: for a sequence
to be considered a potential exogenous plasma sRNA, it
had to be non-identical to any of the sequences assigned
to the confirmed contaminant sequences (Table 1), it
had to be absent from at least 90% of the controls (no-li-
brary controls, water and spike-in controls, eluates and
mock extracts) and never detected in any of these con-
trols with at least 10 copy numbers, and it had to be de-
tected by more than 3 reads in more than 7 of the 28
libraries generated from the plasma titration experiment.
These thresholds were chosen in order to make the ana-
lysis robust against multiplexing errors (e.g. which would
result in false-negative identifications if a sequence that
is very dominant in a plasma sample is falsely assigned
to the control samples), while at the same time making
it sensitive to low-abundant sequences (which would not
be detected in every library). To confirm the non-human
origin and find potential microbial taxa of origin for
these sequences, they were subsequently searched within
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the NCBI nr database using megablast and blastn web
tools, with parameters auto-set for short inputs [76–78].
All sequences with best hits to human sequences or
other vertebrates were removed because they were po-
tentially human. The remaining sequences were matched
against a set of genera previously reported to be com-
mon sequencing kit contaminants [41]. Sequences with
better hits to non-contaminant than contaminant taxa
were kept as potential exogenous sequences.
Additional files
Additional file1: Figure S1. Scheme summarising the different control
experiments, the titration experiments and their outcomes. a) Tracing
non-human sRNA sequences to contaminants on spin columns by
variation of different steps in the isolation protocol and analysis by qPCR
assays. Modifications to the steps named at the top are listed below the
workflow and the outcomes are summarised at the right hand side. b)
Workflow of the titration experiment to determine a minimal safe input
volume for all contaminant sequences. UCP column ultra-clean column.
(PDF 86 kb)
Additional file 2: Table S1. List of the generated datasets with public
accession numbers. Table S2. Analysed published datasets with
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sRNA sequences detected in human plasma after removal of
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genomes were used in the initial analysis. Table S5. List of the eukaryotic
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the initial analysis. Table S6. List of the viruses whose reference genomes
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Data points for Fig. 2d. Table S11. Data points for Fig. 4a. Table S12.
Data points for Fig. 5b. (XLSX 228 kb)
Additional file 3: Figure S2. Detection of contaminants in published
datasets. Heatmap showing the relative abundances of the confirmed
contaminant sequences in published sRNA sequencing data of low-
biomass samples. Only samples for which any of the confirmed
contaminants were detected are shown. Extraction methods: Q regular
QIAGEN miRNeasy; T TRIZOL. rpm reads per million. (PDF 106 kb)
Additional file 4: Figure S3. Detection of contaminants in eluates of
regular and ultra-clean RNeasy columns. Two batches of regular miR-
Neasy columns and four batches of ultra-clean RNeasy columns were
compared. Results are based on sRNA sequencing data of mock extracts,
normalised to the detected levels of spike-in synthetic RNAs. The different
shadings represent reads mapping to the human genome with 2, 1, or 0
mismatches and the different column batches are coloured in the same
colours as in main Fig. 3, as indicated in the legends. (PDF 16 kb)
Additional file 5: Figure S4. Relative abundance of potential
exogenous sRNAs in datasets derived from a plasma sample of one
healthy individual. Detected levels of the 21 potential exogenous sRNA
sequences in preparations using 45 to 1115 μL human plasma and
regular or ultra-clean RNeasy spin columns and in controls without
plasma, including no library, mock extractions and water controls (n = 33).
cpm counts per million. Error bars indicate one standard deviation; data
points are available in Additional file 2: Table S11. (PDF 11 kb)
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